Verona Pharma (VRNA)
(Delayed Data from NSDQ)
$28.71 USD
-0.28 (-0.97%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $28.67 -0.04 (-0.14%) 6:54 PM ET
5-Strong Sell of 5 5
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, Verona Pharma (VRNA) reported earnings of -$0.88 per share, missing the Zacks Consensus Estimate of -$0.35 per share. This reflects a negative earnings surprise of 151.43%. Look out for VRNA's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year decrease of 150%.
Earnings History
Price & Consensus
Zacks News for VRNA
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
VRNA: What are Zacks experts saying now?
Zacks Private Portfolio Services